agilon health (NYSE:AGL) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says

agilon health (NYSE:AGL) had its target price raised by Royal Bank of Canada from $3.00 to $3.50 in a research note issued to investors on Wednesday,Benzinga reports. They currently have an outperform rating on the stock.

A number of other equities analysts also recently weighed in on AGL. Citigroup raised shares of agilon health from a “sell” rating to a “neutral” rating and upped their price target for the stock from $1.75 to $2.25 in a research note on Friday, January 10th. TD Cowen lowered their target price on shares of agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research report on Monday, November 11th. Needham & Company LLC reissued a “hold” rating on shares of agilon health in a research report on Wednesday. Barclays lowered their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Finally, Stifel Nicolaus increased their target price on shares of agilon health from $2.00 to $3.00 and gave the stock a “hold” rating in a research report on Wednesday. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $3.95.

agilon health Price Performance

NYSE AGL opened at $3.29 on Wednesday. The business’s fifty day moving average is $2.91 and its two-hundred day moving average is $3.04. The company has a debt-to-equity ratio of 0.06, a quick ratio of 1.29 and a current ratio of 1.29. agilon health has a 1 year low of $1.50 and a 1 year high of $7.73. The stock has a market capitalization of $1.36 billion, a P/E ratio of -3.50 and a beta of 0.66.

Insider Activity at agilon health

In related news, Director Karen Mcloughlin bought 25,000 shares of agilon health stock in a transaction that occurred on Friday, December 13th. The stock was acquired at an average price of $2.20 per share, for a total transaction of $55,000.00. Following the completion of the purchase, the director now owns 73,166 shares in the company, valued at approximately $160,965.20. This represents a 51.90 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director John William Wulf bought 45,000 shares of agilon health stock in a transaction that occurred on Thursday, December 5th. The stock was bought at an average price of $2.18 per share, with a total value of $98,100.00. Following the purchase, the director now owns 206,133 shares of the company’s stock, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders purchased 77,500 shares of company stock worth $169,600. Company insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. lifted its stake in shares of agilon health by 0.9% in the fourth quarter. Vanguard Group Inc. now owns 31,112,407 shares of the company’s stock valued at $59,114,000 after buying an additional 272,787 shares during the period. Capital International Investors boosted its holdings in agilon health by 72.0% during the fourth quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock valued at $42,431,000 after purchasing an additional 9,346,295 shares in the last quarter. State Street Corp boosted its holdings in agilon health by 3.0% during the third quarter. State Street Corp now owns 7,449,706 shares of the company’s stock valued at $29,277,000 after purchasing an additional 215,733 shares in the last quarter. Millennium Management LLC boosted its holdings in agilon health by 187.8% during the fourth quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock valued at $13,704,000 after purchasing an additional 4,706,357 shares in the last quarter. Finally, Geode Capital Management LLC boosted its holdings in agilon health by 0.5% during the fourth quarter. Geode Capital Management LLC now owns 6,928,724 shares of the company’s stock valued at $13,168,000 after purchasing an additional 35,207 shares in the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.